tapebrief
CEG · Q4 2025
Preliminary brief— based on press release only. Full analysis including management tone and Q&A will be added when the transcript is available.

CEG · Q1 2026 Earnings

Constellation Energy

Reported May 11, 2026

30-second summary

Constellation delivered $11.12B revenue (+63.8% YoY) and $2.74 non-GAAP EPS in its first integrated quarter with Calpine, while reaffirming FY2026 adjusted operating EPS at $11.00–$12.00. The more important signals are qualitative: management declared PJM regulatory clarity "clearly visible at the end of the tunnel" with a June FERC filing now on the calendar, layered in a multi-year FCF outlook of $8.4B for 2026–27 — and quietly dropped the "at least $2B incremental annual FCF" target that anchored last quarter's framing.

Headline numbers

EPS

Q1 FY2026

$2.74

+5.0% vs est.

Revenue

Q1 FY2026

$11.12B

+63.8% YoY

+27.7% vs est.

Operating margin

Q1 FY2026

20.9%

Key financials

Q1 FY2026
MetricQ1 FY2026YoYQ4 FY2025QoQ
Revenue$11.12B+63.8%$6.07B+83.1%
EPS$2.74—$2.30+19.1%
Operating margin20.9%—9.8%+1105bps

Guidance

Constellation reaffirmed full-year FY2026 EPS guidance of $11-$12 while withdrawing specific incremental free cash flow targets; Q1 FY2026 results beat both revenue and EPS expectations with 63.8% YoY revenue growth and 5% EPS surprise.

Guidance is issued for the full year only, refreshed each quarter. Prior and new below are the same FY updated this quarter.

Changes to prior guidance

MetricPeriodPrior guideNew guideΔResult
Free Cash Flow
FY 2026
at least $2 billion of annual incrementalWithdrawn — no replacement—Withdrawn

Reaffirmed unchanged this quarter: Adjusted Operating EPS ($11.00 - $12.00)

Other KPIs

Q1 FY2026
SegmentQ1 FY2026
Nuclear Generation44,666 GWhs
Natural Gas, Oil, and Renewables Generation32,061 GWhs
Nuclear Capacity Factor (excl. Salem/STP)92.3%
Renewable Energy Capture96.7%
Equivalent Forced Outage Factor (EFOF)4.5%
Operating Income$2,332 million
Total Generating Capacity55 GW
Customer Accounts Served2.5 million

Management tone

Q2 commercial positioning → Q3 execution patience → Q4 decisive multi-year framing → Q1 FY2026 regulatory clarity and capability monetization.

For three quarters the PJM regulatory backdrop was the unresolved gating item — Q2 described utility responsiveness improving, Q3 framed deal completion as customer-approval gated, Q4 declared Constellation would "construct deals now regardless of how PJM proceedings resolve." This quarter is the first where management claims the gating item has resolved itself: "The light now is clearly visible at the end of the tunnel in PJM." The supporting evidence — a defined PJM timeline targeting a June FERC submission, described as "faster than we had hoped" — turns Q4's defensive decoupling ("we'll execute anyway") into Q1 FY2026's offensive setup ("the constraint is lifting on a schedule we didn't expect"). This is the single largest tonal shift across the four-quarter arc.

Calpine framing has compressed faster than expected. Q4 said "integration is ahead of schedule"; Q1 FY2026 reframes Calpine as a deployed capability already monetizing the fleet: "I trust that you can now see how supplemental development and commercial capabilities will help us to unlock the value." This is no longer an integration narrative — it's a capability narrative. The Q4 talking point was "we closed faster than planned"; the Q1 FY2026 talking point is "we're already using what we bought." For investors who underwrote the Calpine deal on synergy realization, this is the first quarter where management is implicitly claiming those synergies are visible in the operating numbers — though no specific dollar synergy disclosure was provided.

The capital allocation language has also stepped up. Q4 introduced the $11–$12 FY2026 guide and 20% base-CAGR target; Q1 FY2026 layers in a "strategic capital allocation framework," the $8.4B FCF outlook for 2026–27, and the assertion that the company has "significant opportunity to productively deploy capital over the balance of the decade." Combined with the withdrawn $2B FCF target, the message is that the deployment ceiling is being reset upward — but the floor that anchored the prior quarter is no longer being defended.

What did not change: no new-nuclear cost disclosure (consistent with prior three quarters), no named hyperscaler counterparty disclosed beyond the previously announced CyrusOne Freestone transaction, and no specific Calpine divestiture price disclosure.

Recurring themes management leaned on this quarter:

Base EPS growth >20% through 2029 anchored by nuclear PTC and long-term contractsData center/hyperscaler demand structural and accelerating despite near-term market weaknessPJM regulatory clarity now on expedited path, unlocking bilateral contracting momentumCalpine capabilities (development + commercial) essential to monetizing nuclear/gas fleetFree cash flow acceleration to $11.5-13B (2028-29) from $8.4B (2026-27) with 45% midpoint growthERCOT market undervalued in outer years; capacity demand estimates conservative

Risks management surfaced:

PJM regulatory timeline could slip despite current acceleration signalsERCOT forward market weakness and timing uncertainty on large load interconnectionForced outage factor and operational execution risk as data center demand scalesFERC approval timeline on CIR transfer from Eddystone to Crane (hoping June-July response)Winter Storm Fern-type ancillary charges and grid operator reserve calls impacting cost-to-serve

Answers to last quarter's watch list

The 20% base-earnings CAGR through 2029 — first-year delivery. Management reaffirmed the >20% base EPS growth target through 2029 and added a "10%+ rolling base EPS growth" frame, but did not disclose a Q1 FY2026 base-EPS print separately. The total non-GAAP EPS of $2.74 is on-pace for the $11–$12 total guide, but the base-vs-enhanced split was not broken out on this print. Status: Continue monitoring
A named data center deal counterparty. The CyrusOne Freestone net metering application was approved by the PUCT, with construction underway on the substation and energization expected Q4 FY2026; a Phase 2 exclusive agreement for an additional 380 MW was also disclosed. Management declined to name additional hyperscaler counterparties on this print, citing customer-led announcement timing. Status: Partially resolved
Calpine divestiture disclosure. No specific sale prices or net-proceeds use were disclosed on the print. Calpine integration is now being described as a capability multiplier rather than an asset-disposal exercise. Status: Continue monitoring
Nuclear capacity factor. Q1 FY2026 ex-Salem/STP capacity factor came in at 92.3%, down 180bps YoY from 94.1% in Q1 FY2025, with management attributing the decline to 11 incremental planned refueling outage days. EFOF disclosed at 4.5% as a new operational metric for the gas/oil/pumped-storage fleet. Status: Resolved — explained by outage cadence
New-nuclear cost disclosure. No cost-per-kW figure or uprate program economics disclosed. Status: Continue monitoring
FCF realization vs the $2B+ incremental target. The $2B+ incremental annual FCF target has been withdrawn and replaced with $8.4B cumulative 2026–27 and $11.5–13B for 2028–29. No FY2026-specific FCF figure was disclosed, and there is no replacement falsifiable annual target. Status: Resolved negatively

What to watch into next quarter

PJM FERC filing in June and timeline integrity. Management staked its tonal pivot on the June FERC submission and a June–July FERC response on the CIR transfer from Eddystone to Crane. Watch whether the June filing happens on schedule and whether FERC responds in the hoped-for window — slippage would unwind the "light at the end of the tunnel" framing materially.

The withdrawn $2B FCF target — does a replacement number emerge? Management replaced an annual incremental target with cumulative multi-year ranges. Watch whether Q2 brings any FY2026-specific FCF figure, or whether the longer-horizon framing remains the only disclosure.

Base-EPS progression vs the implied multi-year step. Management reaffirmed the >20% base CAGR through 2029 but didn't disclose Q1 FY2026 base-EPS separately. Watch whether interim disclosures break out the base-vs-enhanced split or whether the metric quietly becomes annual-only.

Named hyperscaler counterparties beyond CyrusOne. With PJM clarity now management's own framing, additional named counterparties become the falsifiable test of whether the regulatory pivot translates into commercial output.

Nuclear capacity factor recovery in FY2026. 92.3% reflects elevated planned outage days in Q1. Watch whether the fleet rebounds into the mid-90s as the refueling schedule normalizes — the operating leverage at current power prices makes 100bps of capacity factor materially earnings-sensitive.

Calpine-related disclosures. Watch for any further detail on integration economics, divestiture proceeds, or quantified synergy realization.

Buyback cadence around the Calpine lockup. Management disclosed $335M of repurchases (~1.2M shares at ~$285) under the $5B authorization; the first 25M-share Calpine lockup expires June 30, 2026. Watch whether a block transaction materializes around that date.

Sources

  1. Constellation Energy Q1 FY2026 press release (SEC filing): https://www.sec.gov/Archives/edgar/data/1868275/000186827526000063/ceg-20260511991.htm
  2. Constellation Energy Q1 FY2026 earnings call transcript (prepared remarks and Q&A)
  3. Constellation Energy Q4 FY2025 brief (tapebrief prior coverage)
  4. Constellation Energy Q3 FY2025 brief (tapebrief prior coverage)
  5. Constellation Energy Q2 FY2025 brief (tapebrief prior coverage)

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.